Eiichi Kodama

Broad Antiretroviral Activity and Resistance Profile of the Novel Human Immunodeficiency Virus Integrase Inhibitor Elvitegravir (JTK-303/GS-9137)

Kazuya Shimura, Eiichi Kodama, Yasuko Sakagami et al. · Journal of Virology · 2007 · 343 citations · Full text

Medicine, Human Retrovirus, Immunology +15

Novel HIV-1 Integrase Inhibitors Derived from Quinolone Antibiotics

Motohide Sato, Takahisa Motomura, Hisateru Aramaki et al. · Journal of Medicinal Chemistry · 2006 · 320 citations · Full text

Quinolone Antibiotics, Medicinal Chemistry, Medicine +14

A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication

Shin-ichiro Hattori, Nobuyo Higashi‐Kuwata, Hironori Hayashi et al. · Nature Communications · 2021 · 190 citations · Full text

Cohort Profile: Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study (TMM BirThree Cohort Study): rationale, progress and perspective

Shinichi Kuriyama, Hirohito Metoki, Masahiro Kikuya et al. · International Journal of Epidemiology · 2019 · 185 citations · Full text

Cohort Profile, Clinical Population, Global Health +8

Remodeling of gp41-C34 Peptide Leads to Highly Effective Inhibitors of the Fusion of HIV-1 with Target Cells We thank Dr. Terrence R. Burke, Jr., NCI, NIH, Frederick, MD 21702-1201, for proofreading the manuscript and providing useful comments. This research was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Japan Society for the Promotion of Science, and the Japan Health Science Foundation.

Akira Otaka, Miki Nakamura, Daisuke Nameki et al. · Angewandte Chemie International Edition · 2002 · 162 citations

Sc Peptides, Peptide Engineering, Immunology +21